Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high21.50 14/12/15
52 week low6.50 12/04/16
52 week change -4.48 (-29.38%)
4 week volume12,033,590 02/09/16

Media for (NIPT)

Latest NewsMore

Holding(s) in Company

RNS Number: 6794K Premaitha Health PLC 23 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Premaitha Health plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An...

Premaitha Health extends investment agreement

Premaitha Health has entered into an extension of the investment agreement with Thermo Fisher Scientific announced on...

Investment agreement extension with Thermo Fisher

RNS Number: 6625K Premaitha Health PLC 23 September 2016 Premaitha Health Plc ("Premaitha" or the "Company") Investment agreement extension with Thermo Fisher Scientific Manchester, UK - 23 September 2016 - Premaitha Health PLC (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, is pleased to announce...

Notice of results & appointment of broker

RNS Number: 6624K Premaitha Health PLC 23 September 2016 Premaitha Health plc ("Premaitha" or the "Company") Notice of results & appointment of broker Manchester, UK - 23 September 2016 - Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, makes the following announcements: Notice...

Premaitha Health's non-exec chair steps down

Premaitha Health said non-executive chairman David Evans has stepped down from the board with immediate effect. No...

Directorate Change

RNS Number: 3078J Premaitha Health PLC 08 September 2016 Premaitha Health plc ("Premaitha" or the "Company") Directorate Change Manchester, UK - 8 September 2016 - Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, announces that David Evans, Non-executive Chairman, has stepped d...

Directorate Change

RNS Number: 3380D Premaitha Health PLC 06 July 2016 Premaitha Health plc ("Premaitha" or the "Company") Directorate Change Manchester, UK - 6 July 2016 - Premaitha Health PLC (AIM: NIPT) announces that Dr Charles Roberts, Non-executive Director, is stepping down from the Board with immediate effect. Dr Roberts was a partner at Loxbridge Research...

Progress on anti-trust objections to litigation

RNS Number: 0684D Premaitha Health PLC 04 July 2016 Premaitha Health plc Progress on anti-trust objections to litigation Manchester, UK - 4 July 2016: Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, provides an update on anti-trust matters it has raised in connection with the patent legal pro...

Fundamental DataMore

EPS-4
Dividend yield0 %

Equity Research (NIPT)

hardman & co
Premaitha Health PLC
20/04/2016
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA® uses complex statistical analysis to determine the likelihood that a fetus is carrying...
hardman & co
Premaitha Health PLC
28/01/2016
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA estimates the risk that a fetus has any of Down’s, Edwards’ or Patau’s syndromes caused...
hardman & co
Premaitha Health PLC
15/12/2015
Premaitha is a molecular diagnostics company that has used the latest advances in DNA technology to develop a non-invasive pre-natal screening test. IONA is its first test, for detection of genetic...

Latest discussion posts More

  • Re: Hardman and Co. re. litigation

    It stinks if you ask me. It is akin to the bully at school (Illumia) pinching dinner money from the school swot (NIPT). Hope it gets resolved soon and the share price ...
    23-Sep-2016
    Mr Papillon
  • Re: Hardman and Co. re. litigation

    Thanks midler2/dyfiman, I agree it's not a cave in, yet. Appears to me that Illumina may just be able to bully the small outfit due to legal costs mounting and the cost for ...
    4-Aug-2016
    InsanityBeckons
  • Hardman and Co. re. litigation

    This is an extract from the current Hardman note. It seems to me that they are suggesting the board MAY be considering negotiation vs. litigation. I don't see it as a cave in - ...
    4-Aug-2016
    middler2

Users' HoldingsMore

Users who hold Premaitha Health also hold..
ROCKHOPPER18%
LLOYDS GRP.17%
GULF KEYSTONE15%
ID:ISIN:BMG4209G124415%
ID:ISIN:BMG4209G132715%

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT